Navigation Links
Standard Methods Miss 50% of Pharmaceutical Key Opinion Leaders
Date:1/28/2010

Social Network Analysis of 11 disease areas shows that current KOL identification methods produce inaccurate results; relationship models are more effective than bibliometric lists in measuring KOL impact

(PRWEB) January 28, 2010 -- A new white paper challenges the generally-held notion that scientists who are “productive” in terms of publishing are well connected and meaningful to the community. Research firm Lnx Pharma found that in a large number of cases, the opposite was true.

This study questions the current methodology used extensively in pharmaceutical and biotech industries to find Key Opinion Leaders (KOLs) and influential thought leaders. KOLs are a key part of pharmaceutical marketing, discovery and development stages.

“Companies typically use a combination of personal referrals plus standard bibliometrics to find and evaluate candidates for advocacy and advisory roles in drug development,” said Philip Topham, General Manager of Lnx Pharma. “They consider it to be more of an art form than science - qualitative information is layered with publishing counts and speaking engagements data in order to judge the potential value of KOLs. We can now quantify that this methodology is leaving a large number of truly respected thought leaders out of the consideration set.”

Lnx Pharma research shows that bibliometrics as a means of discovering and ranking potential product advocates fails to find over 50% of the truly respected experts, compared to using the more advanced Large Scale Social Network Analysis (SNA). Lnx Pharma is a research company that uses SNA to help pharmaceutical companies to map thought leadership and marketing strategies.

The LS-SNA method was used to evaluate more than 20 different disease state areas including:
        

 
  • Obesity
  •         
  • Blood Coagulation Disorders
  •         
  • Infectious Diseases
  •         
  • Autism
  •         
  • Cardiology
  •         
  • Oncology - Breast
  •         
  • Oncology - Lung
  •         
  • Oncology - Ovarian
  •         
  • Oncology - Colorectal
  •         
  • Rheumatology
  •         
  • Central Nervous System
  •         
  • Diagnostics & Biomarkers
  •         
  • Insomnia
  •         
  • Diabetes
The complex relationships between researchers contain a wealth of information that can be extracted using Large Scale Social Network Analysis. Consequently it is only natural to use research publications to identify experts or key opinion leaders (KOLs.) Yet for all the wealth of information, no amount of counting publications will determine “respect.” A person could publish 10 times or 100 times and still not be respected. And yet, companies continue to utilize this outdated an ineffective technique.

The full white paper may be downloaded from the Lnx Pharma website: http://bit.ly/whitepaper6

About Lnx Pharma
Lnx Pharma is a division of Lnx Research, LLC a privately held company based in Irvine, California, dedicated to leadership in the analysis of knowledge-creating communities. Lnx Research utilizes proprietary social network analysis methods and technologies to identify and understand "The Invisible College" of key opinion leaders in order to answer questions about knowledge communities for government and commercial clients in multiple industries. For white papers on this topic, or more specific information on Lnx Pharma, email info(at)lnxpharma(dot)com, or see http://www.lnxpharma.com.

# # #

Read the full story at http://www.prweb.com/releases/pharmaceutical-marketing/kol-management/prweb3538204.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
2. Standard Management Announces OTCBB Listing
3. Gastroenterology sets standards for CT colonography
4. Public Health and Need for Consistent Standards Preclude Exception for Breastfeeding Mother in National Medical Licensing Test
5. New Drug No Substitute for Standard Blood-Clot Therapy
6. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
7. New guidelines set to improve standard of cows milk allergy care
8. Green Seal Ramps Up Environmental Standard for Household Cleaners
9. URAC CEO Testifies Before New Hampshire Legislators Regarding New URAC Standards for Pharmacy Benefit Management
10. Standard treatment for prostate cancer may encourage spread of disease
11. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Standard Methods Miss 50% of Pharmaceutical Key Opinion Leaders 
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: